Tenaya Therapeutics (TNYA) Financials: Revenue & Earnings

TNYA price $0.40 +0.00 +0.40%

Ticker
TNYA
Price
$0.40
Change
+0.00 +0.40%
Market cap ?
$90.36M
P/E ?
-0.77
Forward P/E ?
1.28
Dividend yield ?
0.00%
Beta ?
2.88
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
66
Value
59
Quality
39
Growth
100

Stocklytics score rationale: value 59, quality 39, growth 100.

Financials

2019202020212022202320242025
0000000

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy…

Fair value

TNYA fair value $12.35. Price $0.40. Price is 97% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare TNYA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.10—800.00K
2026-08-05-0.20-0.071.11M10.00M
2026-05-06-0.09-0.09225.00K7.50M
2026-03-11-0.12-0.13—3.00M
2025-11-10-0.12-0.15——
2025-08-06-0.14-0.20——
2025-05-07-0.24-0.18——
2025-03-10-0.28-0.31——
2024-11-06-0.30-0.37——
2024-08-08-0.34-0.40——
2024-05-14-0.40-0.43——
2024-03-18-0.40-0.4517.66M—
2023-11-08-0.39-0.47——
2023-08-09-0.45-0.51——
2023-05-10-0.43-0.60——
2023-03-08-0.61-0.66——
2022-11-10-0.74-0.64——
2022-08-10-0.69-0.75——
2022-05-11-0.75-0.62——
2022-03-23-0.63-0.57——
2021-11-10-0.68-0.81——
2021-09-08-13.26-7.17——
2021-07-30-0.48———
2020-12-31-0.38———
2020-09-30-0.38———
2020-06-30-0.32———
2020-03-31-0.33———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-10Ali FarazBuy732.50K$0.65475.25K
2026-09-10Ali FarazBuy122.00K——
2026-09-10Tingley WhittemoreBuy293.00K$0.65190.10K
2026-09-10Tingley WhittemoreBuy49.00K——
2026-08-17Ali FarazSell5.84K$0.714.14K
2026-08-17Ali FarazSell3.97K$0.712.82K
2026-08-17Ali FarazSell5.02K$0.713.56K
2026-08-17Ali FarazSell7.41K$0.715.26K
2026-08-17Tingley WhittemoreSell1.64K$0.711.16K
2026-08-17Tingley WhittemoreSell1.64K$0.711.16K
2026-08-17Tingley WhittemoreSell1.87K$0.711.33K
2026-08-17Tingley WhittemoreSell2.28K$0.711.62K
2026-07-13Hyllengren Eric JOther0——
2026-07-13Hyllengren Eric JBuy1.65M$0.841.38M
2026-05-28Williams R SandersBuy120.00K$0.8095.87K
2026-05-28Walsh Jeffrey T.Buy120.00K$0.8095.87K
2026-05-28Stehman-Breen CatherineBuy120.00K$0.8095.87K
2026-05-28Srivastava DeepakBuy120.00K$0.8095.87K
2026-05-28Parschauer Karah HerdmanBuy120.00K$0.8095.87K
2026-05-28Lee JuneBuy120.00K$0.8095.87K
2026-05-28Burroughs Amy L.Buy120.00K$0.8095.87K
2026-05-18Ali FarazSell3.39K$0.792.69K
2026-05-18Tingley WhittemoreSell3.12K$0.792.48K
2026-05-18Higa TomohiroSell1.49K$0.791.18K
2026-02-25COLUMN GROUP III GP, LPSell1.86M$0.561.05M
2026-02-24COLUMN GROUP III GP, LPSell349.21K$0.62214.87K
2026-02-24COLUMN GROUP III GP, LPSell309.23K$0.62190.27K
2026-02-23COLUMN GROUP III GP, LPSell162.29K$0.6096.92K
2026-02-23COLUMN GROUP III GP, LPSell143.71K$0.6085.82K
2026-02-20COLUMN GROUP III GP, LPSell277.77K$0.61170.80K
2026-02-20COLUMN GROUP III GP, LPSell245.97K$0.61151.24K
2026-02-17Higa TomohiroSell611$0.64393
2026-02-17Higa TomohiroSell836$0.64538
2026-02-17Higa TomohiroSell2.02K$0.641.30K
2026-02-17Ali FarazSell5.85K$0.643.76K
2026-02-17Ali FarazSell3.98K$0.642.56K
2026-02-17Ali FarazSell5.03K$0.643.24K
2026-02-17Tingley WhittemoreSell1.64K$0.641.06K
2026-02-17Tingley WhittemoreSell1.64K$0.641.06K
2026-02-17Tingley WhittemoreSell1.88K$0.641.21K
2026-02-11COLUMN GROUP III GP, LPSell2.15M$0.681.46M
2026-02-11COLUMN GROUP III GP, LPSell1.91M$0.681.30M
2026-02-10COLUMN GROUP III GP, LPSell182.29K$0.82148.77K
2026-02-10COLUMN GROUP III GP, LPSell161.42K$0.82131.74K
2026-02-03Higa TomohiroBuy175.50K$0.92160.58K
2026-02-03Higa TomohiroBuy29.25K——
2026-02-03Tingley WhittemoreBuy318.50K$0.92291.43K
2026-02-03Tingley WhittemoreBuy48.75K——
2026-02-03Ali FarazBuy952.25K$0.92871.31K
2026-02-03Ali FarazBuy158.60K——
2025-11-17Higa TomohiroSell1.37K$1.331.82K
2025-11-17Tingley WhittemoreSell2.88K$1.333.83K
2025-11-17Ali FarazSell3.13K$1.334.16K
2025-08-18Higa TomohiroSell523$1.25655
2025-08-18Higa TomohiroSell717$1.25898
2025-08-18Higa TomohiroSell1.72K$1.252.16K
2025-08-18Tingley WhittemoreSell1.61K$1.252.01K
2025-08-18Tingley WhittemoreSell1.61K$1.252.01K
2025-08-18Tingley WhittemoreSell1.84K$1.252.30K
2025-08-18Ali FarazSell5.72K$1.257.17K
2025-08-18Ali FarazSell3.89K$1.254.88K
2025-08-18Ali FarazSell4.92K$1.256.16K
2025-05-29Stehman-Breen CatherineBuy107.40K$0.4447.73K
2025-05-29Walsh Jeffrey T.Buy107.40K$0.4447.73K
2025-05-29Burroughs Amy L.Buy107.40K$0.4447.73K
2025-05-29GOEDDEL DAVID VBuy107.40K$0.4447.73K
2025-05-29Williams R SandersBuy107.40K$0.4447.73K
2025-05-29Srivastava DeepakBuy107.40K$0.4447.73K
2025-05-29Lee JuneBuy107.40K$0.4447.73K
2025-05-29Parschauer Karah HerdmanBuy107.40K$0.4447.73K
2025-05-16Higa TomohiroSell1.39K$0.44615
2025-05-16Tingley WhittemoreSell2.94K$0.441.30K
2025-05-16Ali FarazSell3.19K$0.441.41K
2025-03-10Higa TomohiroSell1.02K$0.54548
2025-03-10Higa TomohiroSell620$0.54334
2025-03-10Higa TomohiroSell845$0.54455
2025-03-10Tingley WhittemoreSell1.73K$0.54930
2025-03-10Tingley WhittemoreSell4.07K$0.542.19K
2025-03-10Tingley WhittemoreSell1.60K$0.54860
2025-03-10Ali FarazSell5.79K$0.543.12K
2025-03-10Ali FarazSell3.95K$0.542.13K
2025-03-05COLUMN GROUP III GP, LPBuy35.71M$0.7025.00M
2025-03-05COLUMN GROUP III GP, LPBuy35.71M$0.8028.57M
2025-03-05COLUMN GROUP III GP, LPBuy17.86M$0.7012.50M
2025-03-05GOEDDEL DAVID VBuy35.71M$0.7025.00M
2025-03-05GOEDDEL DAVID VBuy35.71M$0.8028.57M
2025-03-05GOEDDEL DAVID VBuy17.86M$0.7012.50M
2025-02-24Higa TomohiroOther50.00K$1.2160.50K
2025-02-06Higa TomohiroOther0——
2025-02-06Higa TomohiroOther0——
2025-02-06Ali FarazBuy650.00K$1.00650.00K
2025-02-06Ali FarazBuy401.39K$1.21485.68K
2025-02-06Ali FarazBuy353.27K$1.21427.46K
2025-02-06Ali FarazBuy34.42K——
2025-02-06Ali FarazBuy107.50K——
2025-02-06Ali FarazBuy161.21K$1.21195.07K
2025-02-06Ali FarazSell401.39K$15.196.10M
2025-02-06Ali FarazSell353.27K$5.641.99M
2025-02-06Ali FarazSell161.21K$9.361.51M
2025-01-24Tingley WhittemoreBuy235.00K$1.21284.35K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 108, holders 0 vs prior quarter. Ownership 24.86%.

HolderSharesChangeChange %Value
VANGUARD CAPITAL MANAGEMENT LLC7.10M-1.38M-16.28%5.25M
MILLENNIUM MANAGEMENT LLC6.43M972.98K+17.83%4.75M
CITADEL ADVISORS LLC4.57M4.39M+2494.76%3.38M
RENAISSANCE TECHNOLOGIES LLC4.28M567.34K+15.28%3.16M
BLACKROCK, INC.4.01M304.76K+8.23%2.96M
EMPERY ASSET MANAGEMENT, LP3.86M-423.82K-9.89%2.86M
MARSHALL WACE, LLP3.50M797.79K+29.49%2.59M
GSA CAPITAL PARTNERS LLP2.67M1.60M+148.77%1.97M
BURKEHILL GLOBAL MANAGEMENT, LP2.00M00.00%1.48M
GEODE CAPITAL MANAGEMENT, LLC1.83M274.74K+17.61%1.36M
ADAR1 CAPITAL MANAGEMENT, LLC1.56M47.70K+3.16%1.15M
RAIFFEISEN BANK INTERNATIONAL AG1.20M200.00K+20.00%881.88K
EUCLIDEAN CAPITAL LLC1.02M00.00%750.71K
VANGUARD FIDUCIARY TRUST CO987.50K-28.20K-2.78%729.77K
MIRADOR CAPITAL PARTNERS LP905.10K18.18K+2.05%668.96K
STATE STREET CORP708.72K00.00%523.82K
SQUAREPOINT OPS LLC659.25K310.98K+89.29%487.25K
STEPSTONE GROUP LP462.16K00.00%341.54K
UBS GROUP AG456.56K-208.62K-31.36%337.39K
JANE STREET GROUP, LLC450.44K435.63K+2943.48%332.92K
TWO SIGMA INVESTMENTS, LP380.79K-899.60K-70.26%281.44K
CASDIN CAPITAL, LLC361.97K00.00%267.53K
INVESCO LTD.354.86K216.86K+157.14%262.28K
NORTHERN TRUST CORP346.37K35.72K+11.50%256.00K
SUSQUEHANNA INTERNATIONAL GROUP, LLP325.32K271.42K+503.55%240.44K

Earnings and financials

Tenaya Therapeutics, Inc. (TNYA) trades at $0.40, with a market cap of $90.36M and a trailing P/E of -0.77. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
0000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Tenaya Therapeutics (TNYA) Financials: Revenue & Earnings

TNYA$0.40+0.00 +0.40%

$90.36M

Market Cap

-0.77

P/E

1.28

Forward P/E

66

Score

Price History